Biologic Gray Zone of Melanocytic Tumors, Fiction or Reality?

Biologic Gray Zone of Melanocytic Tumors, Fiction or Reality?

Authors

  • Harald Kittler Department of Dermatology, Medical University of Vienna, Vienna, Austria

References

Ackerman LV. Malignant melanoma of the skin; clinical and pathologic analysis of 75 cases. Am J Clin Pathol. 1948;18: 602–624.

Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953;6: 1–45.

Elder DE, Green MH, Guerry D 4th, Kraemer KH, Clark WH Jr. The dysplastic nevus syndrome: our definition. Am J Dermatopathol. 1982 Oct;4(5):455-60.

Ho J, Collie CJ. What's new in dermatopathology 2023: WHO 5th edition updates. J Pathol Transl Med. 2023 Nov;57(6):337-340.

Acosta JN, Falcone GJ, Rajpurkar P, Topol EJ. Multimodal biomedical AI. Nat Med. 2022 Sep;28(9):1773-1784

Barata C, Rotemberg V, Codella NCF, Tschandl P, Rinner C, Akay BN, Apalla Z, Argenziano G, Halpern A, Lallas A, Longo C, Malvehy J, Puig S, Rosendahl C, Soyer HP, Zalaudek I, Kittler H. A reinforcement learning model for AI-based decision support in skin cancer. Nat Med. 2023 Aug;29(8):1941-1946.

Downloads

Published

2024-04-30

How to Cite

1.
Biologic Gray Zone of Melanocytic Tumors, Fiction or Reality?. Dermatol Pract Concept [Internet]. 2024 Apr. 30 [cited 2024 Oct. 9];14(2):e2024148. Available from: https://dpcj.org/index.php/dpc/article/view/4423

Share